AIP
CORV

ARS Investment Partners’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

ARS Investment Partners’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-147,818
Closed -$61K – 117
2019
Q4 		$61K Sell
147,818
-67,900
-31% -$113K 0.01% 112
2019
Q3 		$431K Sell
215,718
-206,405
-49% -$418K 0.08% 82
2019
Q2 		$912K Buy
422,123
+84,255
+25% +$215K 0.15% 78
2019
Q1 		$1.07M Buy
337,868
+4,013
+1% +$13K 0.19% 71
2018
Q4 		$831K Buy
333,855
+54,915
+20% +$183K 0.18% 75
2018
Q3 		$1.12M Buy
+278,940
New +$1.23M 0.17% 80

Other funds holding CORV

BCM
Beryl Capital Management Redondo Beach, California $109M AUM 317.92% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $674M AUM 24.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $3.03B AUM 104.56% 1-Year Est. Return